SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

AISAP raises $13 Million in Seed for its AI ultrasound solution

Sam Altman-backed Apex emerges from stealth with $7M to help secure AI adoption

Gigi Levy-Weiss: "Creating jobs is no longer enough to fulfill one’s Zionist duty; we must change the country"

Full list of Israeli high-tech funding rounds in 2024

Buzz

Most popular

Daily

Weekly

1

Wiz deal to acquire Lacework collapses

2

Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale

3

Cyber startup Oasis secures $35 million Series A extension, doubles valuation

4

Nvidia to acquire AI startup Deci for $300 million

5

"Israel definitely needs to reconsider its strategy towards China"

Biosimilars

2 stories about Biosimilars

קור שולץ מנכ"ל טבע 9.11.19

Teva Is Pulling an Ace From its Sleeve in its Attempt to Reinvent Itself

11.11.19|Uri Tal-Tene

With one anti-cancer biosimilar launching this week and another expected to hit the market soon, Teva could be creating a new growth engine worth hundreds of millions of dollars a year

מנכ"ל טבע החדש קור שולץ 2

Copaxone Profit will Continue to Fall, But Teva is Set to Double Down on Biosimilars

08.01.19|Lilach Baumer and Hezi Sternlicht

Speaking at J.P. Morgan’s Healthcare Conference on Monday, CEO Kåre Schultz said he expects the U.S. generic market to stabilize in 2019